BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36184734)

  • 1. Approach to the Patient: Management and the Long-term Consequences of Graves' Disease in Children.
    Rivkees SA
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3408-3417. PubMed ID: 36184734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Graves' disease: controversies in management.
    Rivkees SA
    Horm Res Paediatr; 2010; 74(5):305-11. PubMed ID: 20924158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term thionamide antithyroid treatment of Graves' disease.
    Azizi F; Abdi H; Amouzegar A; Habibi Moeini AS
    Best Pract Res Clin Endocrinol Metab; 2023 Mar; 37(2):101631. PubMed ID: 35440398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of methimazole before the administration of radioactive iodine in the management of Graves' disease: a systematic review and meta-analysis.
    Bolakale-Rufai IK; Abioro I; Ngene SO; Woldeamanuel Y
    Sao Paulo Med J; 2023; 141(5):e2022225. PubMed ID: 36629663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definitive treatment of Graves' disease in children and adolescents.
    Król A; Czarniecka A; Jarząb B
    Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Graves' hyperthyroidism: present and future.
    Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
    Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controversies in the management of Graves' disease in children.
    Rivkees SA
    J Endocrinol Invest; 2016 Nov; 39(11):1247-1257. PubMed ID: 27153850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
    Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
    J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies in the pharmacological treatment of Graves' disease in children.
    De Luca F; Valenzise M
    Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1113-1121. PubMed ID: 30417713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of long-term follow-up and methimazole therapy outcomes of pediatric Graves' disease: a single-center experience.
    Bayramoğlu E; Elmaogulları S; Sagsak E; Aycan Z
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):341-346. PubMed ID: 30862763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of Graves' disease in children.
    Rivkees SA
    J Pediatr Endocrinol Metab; 2006 Sep; 19(9):1095-111. PubMed ID: 17128557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Graves' disease: management in the post-propylthiouracil Era.
    Rivkees SA
    Int J Pediatr Endocrinol; 2014; 2014(1):10. PubMed ID: 25089127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
    Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
    Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine treatment in pediatric Graves' disease and thyroid carcinoma.
    Yuan L; Yang J
    J Pediatr Endocrinol Metab; 2011; 24(11-12):877-83. PubMed ID: 22308835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
    Toderian AB; Lawson ML
    Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tale of radioiodine and Graves' orbitopathy.
    Ponto KA; Zang S; Kahaly GJ
    Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
    Mihailescu DV; Hoscheit C; Fogelfeld L
    Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Antithyroid Drug Treatment of Graves' Disease in Children and Adolescents: A 20-Year Single-Center Experience.
    Song A; Kim SJ; Kim MS; Kim J; Kim I; Bae GY; Seo E; Cho YS; Choi JY; Cho SY; Jin DK
    Front Endocrinol (Lausanne); 2021; 12():687834. PubMed ID: 34194397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
    Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
    Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.